Cargando…

Management of tubal ectopic pregnancy with methotrexate in the setting of symptomatic Coronavirus disease 2019 (COVID-19): A case report

BACKGROUND: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19. OBJECTIVE: We present the management of a patient with multiple medical comorbidities and tubal EP...

Descripción completa

Detalles Bibliográficos
Autores principales: Millan, NM, Morano, J, Florez, L, Carugno, J, Medina, CA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universa Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823271/
https://www.ncbi.nlm.nih.gov/pubmed/34555882
http://dx.doi.org/10.52054/FVVO.13.3.030
Descripción
Sumario:BACKGROUND: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19. OBJECTIVE: We present the management of a patient with multiple medical comorbidities and tubal EP in the setting of severe symptomatic COVID-19 infection where all management options were precluded. METHODS: Case report with literature review of management of tubal EP in the setting of severe symptomatic COVID-19 infection. RESULT: After careful consideration of options, the patient underwent successful medical management with methotrexate while receiving supportive care for COVID-19. CONCLUSIONS: Methotrexate proved to be the safest therapeutic option in this patient. Management of patients with severe COVID-19 and gynaecologic emergencies should be individualised and carefully reviewed with evolving knowledge of COVID-19.